Musculoskeletal Diseases  >>  methylprednisolone acetate  >>  Phase 4
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone acetate / Generic mfg.
2016-002991-28`ACTRN12620001349932: The GRASP Trial - "Getting it Right: Addressing Shoulder Pain"

Ongoing
4
704
Europe
Methylprednisolone acetate, Triamcinolone acetonide, Injection, Solution for injection, Depo-Medrone, Kenalog
University of Oxford, NIHR Health Technology Assessment Programme
Pulmonary Hypertension, Right heart failure
 
 
LESS, NCT01238536: Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial ( Trial)

Completed
4
400
US
Epidural steroid with local anesthetic injection, Epidural local anesthetic injection, Epidural steroid injection, Kenalog, depo-medrol, betamethasone or dexamethasone, lidocaine
University of Washington, Kaiser Permanente, University of California, San Francisco, Henry Ford Hospital, Harvard Pilgrim Health Care, Harvard Vanguard Medical Associates, University of Colorado, Denver, Mayo Clinic, Stanford University, Massachusetts General Hospital, Virginia Spine Research Institute, Oregon Health and Science University, Dallas VA Medical Center
Spinal Stenosis, Low Back Pain
08/13
09/15
NCT01994759: Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.

Completed
4
90
Europe
Training, Heavy slow resistance exercise, Eccentric training, stretching, Glucocorticosteroid injection, Methylprednisolone, Depo-medrol, Reduction in impact, Shock absorbtion
Bispebjerg Hospital, Fonden for Faglig Udvikling af Speciallægepraksis, Denmark
Plantar Fasciitis
07/15
12/16
2016-001906-41: A randomised control trial of knee injections for relief of pain in osteoarthritis: A comparison of corticosteroid and NSAID injections

Ongoing
4
78
Europe
Ketorolac Trometamol, Methylprednisolone Acetate, SUB02835MIG, SUB03255MIG, Solution for injection, Ketorolac Trometamol, Depo-medrone (Methylprednisolone Acetate)
Royal College of Surgeons in Ireland, Dept of Orthopaedic Surgery, MRHT, Tullamore, Co Offaly
Knee osteoarthritis is the condition of interest. Osteoarthritis is a common musculoskeletal complaint, with an underlying pathogenesis related to bio-mechanical stress loading, resulting in initial changes within the articular cartilage, progressing to develop cartilage fibrillation; vertical clefts and eventual exposure of subchondral bone and eburnation, Knee osteoarthritis is the condition of interest, which is a condition characterised by the wearing down of the protective cartilage within the knee, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
NCT02448316: Plantar Fasciitis, Operation or Conservative Treatment

Completed
4
30
Europe
endoscopic surgery, Fascial release, Heel spur resection, Training, methylprednisolon, Depo-medrol, Glucocorticosteroid injection, lidokaine, Xylocain, strength training, stretching
Bispebjerg Hospital, The Danish Rheumatism Association
Plantar Fasciitis
11/16
11/17
2018-001085-42: POISE - Psoriatic Oligoarthritis Intervention with Symptomatic thErapy

Not yet recruiting
4
60
Europe
Methylprednisolone acetate BP, Triamcinolone acetonide, Injection, Methylprednisolone acetate BP, Triamcinolone acetonide
University of Oxford, NIHR
Psoriatic Arthritis (PsA) is an inflammatory arthritis. PsA is a highly heterogenous disease with a proportion of participants having mild non-progressive disease. Well validated prognostic factors in PsA can identify these Participants including number of active joints, systemic inflammation levels, radiographic damage and functional ability at presentation. There is little research addressing outcomes and treatment options for mild disease., Psoriatic arthritis causes inflammation in and around the joints. It usually affects people who already have psoriasis, a skin condition that causes a red, scaly rash., Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2020-002285-14: Effectiveness of corticosteroid injection in treatment of trigger fingers: a double blinded randomized clinical trial

Not yet recruiting
4
300
Europe
depo-medrol, Kenacort, Kenacort-40, 8719497000913, Injection, Concentrate for solution for injection, Solution for injection, - Depo-Medrol: ATC code H02AB04 – Methylprednisolone: RVG code 00605, Kenacort-10 H02AB08 - Triamcinolone acetonide RVG code 01591, Kenacort-40 H02AB08 - Triamcinolone acetonide RVG code 05341
JEROEN BOSCH HOSPITAL, Jeroen Bosch Hospital
Trigger finger (stenosing tenosynovitis) is one of the most common conditions seen by hand surgeons,Although not a severe disease, trigger fingers give disabling complaints in performance of work and ADL activities. The triggering is caused by a size mismatch between the first annular pulley (A1) and the corresponding flexor tendon sheath, but the precise etiology still remains unclear.2-4 Most often, trigger fingers do not resolve spontaneously and need some kind of treatment., A triggerfinger is a disease of the flexor tendon tunnel. It is too narrow due irritation that causes difficulty of the tendon to move in the tunnel., Diseases [C] - Musculoskeletal Diseases [C05]
 
 

Download Options